Business Units

 Our-Capacity-MayBaker

May & Baker operates under three major business units and four subsidiaries. These are the Pharmaceutical Manufacturing Business, The Beverages Business and the Foods Business. The subsidiaries are Biovaccines Nigeria Limited, Osworth Nigeria Limited, Servisure Nigeria Limited and Tydipacks Nigeria Limited. While Biovaccines is a partnership with the Federal Government of Nigeria for local production of human vaccines, Servisure, Osworth and Tydipacks are brand owning healthcare companies.

The pharmaceutical manufacturing operations is carried out in two factory locations at Ikeja in Lagos State and Ota in Ogun state. In Ikeja are a Liquid manufacturing plant, a Solid Manufacturing Plant, an ARV plant and Bectaletam plant. The total capacity for solid medicines in Ikeja is 2 billion tablets while there is capacity for 19 million bottles of  Liquid preparations of 60 ml.

The new pharmaceutical plant in Ota, the M&B Pharmacentre has capacity to produce 4 billion tablets and 30 million bottles of 60 ml liquid preparations annually.

The combined capacity of May & Baker’s pharmaceutical business is therefore in excess of 6 billion tablets and 49 million bottles of liquid preparations per annum for a range of over 80 products.

The Beverage Business is located in Ikeja and is currently involved in the bottling of Lily table water while the Food business produces a leading instant noodles, Mimee Noodles.

Picture Speaks

Tweet May & Baker

May & Baker Vacancies

job openings